Endocarditis Caused by<i>Staphylococcus aureus</i>with Reduced Susceptibility to Vancomycin

Christopher W. Woods, Allen Cheng, Vance G. Fowler, Mary Moorefield, Joyce Frederick, George Sakoulas, Venkata G. Meka, Fred C. Tenover, Peter Zwadyk, Kenneth H. Wilson

Clinical Infectious Diseases · 2004 · 43 citations · 14 references

DOIFull text

Open access

Concepts

Abstract

Clinical management of infective endocarditis (IE) is expected to become more difficult with the emergence of Staphylococcus aureus with reduced susceptibility to vancomycin (SARV) in the United States and worldwide. We report the strain characterization and treatment of a patient with SARV IE.

References

14